NHS Logo

Multiple Myeloma - A New Era of Treatment Strategies (Record no. 90786)

MARC details
000 -LEADER
fixed length control field 02259cam a2200409Mu 4500
001 - CONTROL NUMBER
control field ocn779141401
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240729130942.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION
fixed length control field m d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr |n|
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 120305s2012 xx o 000 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency EBLCP
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9781608052974 (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 1608052974 (electronic bk.)
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)779141401
035 ## - SYSTEM CONTROL NUMBER
System control number 500767
-- (N$T)
072 #7 - SUBJECT CATEGORY CODE
Subject category code HEA
Subject category code subdivision 039030
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 062000
Source bisacsh
049 ## - LOCAL HOLDINGS (OCLC)
Holding library N$TA
100 1# - MAIN ENTRY--PERSONAL NAME
Personal author Podar, Klaus.
245 10 - TITLE STATEMENT
Title Multiple Myeloma - A New Era of Treatment Strategies
Medium [electronic resource].
260 ## - PUBLICATION INFORMATION
Place of publication Sharjah :
Publisher Bentham Science Publishers,
Date 2012.
300 ## - PHYSICAL DESCRIPTION
Physical description 1 online resource (217 p.)
505 0# - CONTENTS
Contents 01 Multiple Myeloma -- A New Era of Treatment Strategies.pdf; 02 Cover Page; 03 REVISED eBooks End User License Agreement-Website; 04 TABLE OF CONTENTS; 05 Foreword; 06 PREFACE; 07 Contributors; 08 Section 1; 09 Chapter 01; 10 Chapter 02; 11 Chapter 03; 12 Section 2; 13 Chapter 04; 14 Chapter 05; 15 Chapter 06; 16 Chapter 07; 17 Chapter 08; 18 Section 3; 19 Chapter 9; 20 Chapter 10; 21 Chapter 11; 22 Section 4; 23 Chapter 12; 24 Chapter 13; 25 INDEX.
520 ## - ABSTRACT
Abstract Multiple Myeloma (MM), the second most common blood cancer in adults, is a clonal plasma cell malignancy within the bone marrow characterized by osteolytic bone lesions, renal disease, and immunodeficiency. It is now well established that MM cell- induced disruption of the bone marrow homeostasis between the highly organized cellular and extracellular compartments supports MM cell proliferation, survival, migration, and drug resistance via activation of various signaling pathways. Based on this knowledge, the prototypic drugs thalidomide, bortezomib, and lenalidomide, which target both MM cell.
650 #4 - SUBJECT HEADINGS
Subject term Multiple myeloma.
9 (RLIN) 7046
650 #4 - SUBJECT HEADINGS
Subject term Medicine.
650 #0 - SUBJECT HEADINGS
Subject term Multiple myeloma
General subdivision Treatment.
700 1# - ADDED PERSONAL NAME
Added personal author Anderson, Kenneth C.
856 ## - ONLINE RESOURCE
Uniform Resource Identifier <a href="#gotoholdings">#gotoholdings</a>
Link text Access resource
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Suppress in OPAC Do not Suppress in OPAC
588 ## - SOURCE OF DESCRIPTION NOTE
Source of description note Description based on print version record.
938 ## -
-- EBL - Ebook Library
-- EBLB
-- EBL864207
938 ## -
-- EBSCOhost
-- EBSC
-- 500767
910 ## - USER-OPTION DATA (OCLC)
User-option data cpp1723AUTO
994 ## -
-- 02
-- N$T
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Shelving location Date acquired Source of acquisition Total Checkouts Date last seen Uniform Resource Identifier Price effective from Koha item type
        Stenhouse Library (Kingston Hospital) Stenhouse Library (Kingston Hospital) Online 28/11/2022 eBook EBSCO clinical collection   28/11/2022 https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=500767 28/11/2022 Electronic book
London Health Libraries Consortium Privacy notice and Membership terms and conditions